Literature DB >> 25149164

Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease.

Kristopher T Kimmell1, Kevin A Walter.   

Abstract

Patients undergoing neurosurgical procedures for neoplasia have historically been considered at higher risk for developing venous thromboembolism (VTE). We sought to identify risk factors associated with VTE in patients undergoing craniotomy for tumor resection. We reviewed a national surgical quality database (American College of Surgeons National Surgical Quality Improvement Project, ACS-NSQIP, http://site.acsnsqip.org/ ). Patients undergoing non-emergent craniotomy for neoplastic indications were identified based on current procedural terminology codes. Clinical factors were identified that were associated with VTE events. 3,098 patients who underwent non-emergent craniotomy were identified. 1,741 patients underwent procedures for neoplastic disease (56.2 %). The rate of DVT in these patients was 3.2 % compared to 1.4 % in other neurosurgical patients (OR 2.30, CI 2.29-2.30). The rate of pulmonary embolism was 1.8 % compared to 0.5 % (OR 3.61, CI 3.60-3.62). Univariate analysis identified several factors correlated with VTE. Pre-operative characteristics associated with VTE were the presence of impaired sensorium, dependent functional status, and age > 60 years. Total operative time > 4 h was associated with VTE. Post-operative events associated with VTE included pneumonia, unplanned intubation, fail to wean from ventilator, UTI, stroke, sepsis and septic shock. Age > 60, OR time > 4 h, UTI, and septic shock were significantly associated with VTE in multivariate analysis. Patients undergoing craniotomy for neoplasm are at increased risk of VTE. This risk appears to be modified by pre-operative medical comorbidities, longer operative time, and post-operative complications.

Entities:  

Mesh:

Year:  2014        PMID: 25149164     DOI: 10.1007/s11060-014-1587-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  53 in total

1.  Post-operative thromboembolism in neurosurgery. A study on the prophylactic effect of calf muscle stimulation plus dextran compared to low-dose heparin.

Authors:  S Boström; E Holmgren; O Jonsson; S Lindberg; B Lindström; I Winsö; B Zachrisson
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

2.  Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals.

Authors:  Bruce L Hall; Barton H Hamilton; Karen Richards; Karl Y Bilimoria; Mark E Cohen; Clifford Y Ko
Journal:  Ann Surg       Date:  2009-09       Impact factor: 12.969

3.  Safety of mini-dose heparin administration for neurosurgical patients.

Authors:  H G Barnett; J R Clifford; R C Llewellyn
Journal:  J Neurosurg       Date:  1977-07       Impact factor: 5.115

4.  PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma.

Authors:  J R Perry; J A Julian; N J Laperriere; W Geerts; G Agnelli; L R Rogers; M G Malkin; R Sawaya; R Baker; A Falanga; S Parpia; T Finch; M N Levine
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

5.  Expression of tissue factor correlates with grade of malignancy in human glioma.

Authors:  K Hamada; J Kuratsu; Y Saitoh; H Takeshima; T Nishi; Y Ushio
Journal:  Cancer       Date:  1996-05-01       Impact factor: 6.860

Review 6.  The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis.

Authors:  P Poredos; M K Jezovnik
Journal:  Int Angiol       Date:  2007-12       Impact factor: 2.789

7.  Morbidity and mortality of craniotomy for excision of supratentorial gliomas.

Authors:  C Fadul; J Wood; H Thaler; J Galicich; R H Patterson; J B Posner
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

8.  Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy.

Authors:  R Loch Macdonald; Chris Amidei; Joseph Baron; Bryce Weir; Frederick Brown; Robert K Erickson; Javad Hekmatpanah; David Frim
Journal:  Surg Neurol       Date:  2003-05

Review 9.  How I treat isolated distal deep vein thrombosis (IDDVT).

Authors:  Gualtiero Palareti
Journal:  Blood       Date:  2014-01-28       Impact factor: 22.113

10.  The risk and efficacy of anticoagulant therapy in the treatment of thromboembolic complications in patients with primary malignant brain tumors.

Authors:  E Altschuler; H Moosa; R G Selker; F T Vertosick
Journal:  Neurosurgery       Date:  1990-07       Impact factor: 4.654

View more
  15 in total

1.  Predictors of Venous Thromboembolism After Nonemergent Craniotomy: A Nationwide Readmission Database Analysis.

Authors:  Ian A Buchanan; Michelle Lin; Daniel A Donoho; Arati Patel; Li Ding; Arun P Amar; Steven L Giannotta; William J Mack; Frank Attenello
Journal:  World Neurosurg       Date:  2018-11-20       Impact factor: 2.104

2.  Risk of Venous Thromboembolism in Patients with Large Hemispheric Infarction Undergoing Decompressive Hemicraniectomy.

Authors:  Nohra Chalouhi; Badih Daou; Fred Rincon; Maria Montano; Anthony Kent; Kaitlyn Barkley; Robert M Starke; Stavropoula Tjoumakaris; David Hasan; Richard Dalyai; Robert Rosenwasser; Pascal Jabbour
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

3.  Adverse Events After Microvascular Decompression: A National Surgical Quality Improvement Program Analysis.

Authors:  David J Cote; Hormuzdiyar H Dasenbrock; William B Gormley; Timothy R Smith; Ian F Dunn
Journal:  World Neurosurg       Date:  2019-05-11       Impact factor: 2.104

4.  Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis.

Authors:  Aditya V Karhade; Luis Fandino; Saksham Gupta; David J Cote; Julian B Iorgulescu; Marike L Broekman; Linda S Aglio; Ian F Dunn; Timothy R Smith
Journal:  J Neurooncol       Date:  2016-11-18       Impact factor: 4.130

5.  Patterns of seizure prophylaxis after oncologic neurosurgery.

Authors:  Brett E Youngerman; Evan F Joiner; Xianling Wang; Jingyan Yang; Mary R Welch; Guy M McKhann; Jason D Wright; Dawn L Hershman; Alfred I Neugut; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2019-12-13       Impact factor: 4.130

6.  Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis.

Authors:  Joeky T Senders; Nicole H Goldhaber; David J Cote; Ivo S Muskens; Hassan Y Dawood; Filip Y F L De Vos; William B Gormley; Timothy R Smith; Marike L D Broekman
Journal:  J Neurooncol       Date:  2017-10-16       Impact factor: 4.130

7.  Thirty-Day Morbidity Associated with Pelvic Fixation in Adult Patients Undergoing Fusion for Spinal Deformity: A Propensity-Matched Analysis.

Authors:  Parth Kothari; Sulaiman Somani; Nathan J Lee; Javier Z Guzman; Dante M Leven; Branko Skovrlj; Jeremy Steinberger; Jun Kim; Samuel K Cho
Journal:  Global Spine J       Date:  2017-02-01

Review 8.  Silent pulmonary thromboembolism in neurosurgery patients: Report of 2 cases and literature review.

Authors:  Rui Tian; Jun Gao; Alof Chen; Xinjie Bao; Jian Guan; Ming Feng; Yongning Li; Wenbin Ma; Zuyuan Ren; Renzhi Wang; Junji Wei
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 9.  Venous Thromboembolism in Patients With Brain Cancer: Focus on Prophylaxis and Management.

Authors:  Sohaip Kabashneh; Samer Alkassis; Layla Shanah; Ala A Alkofahi
Journal:  Cureus       Date:  2020-06-22

10.  Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients.

Authors:  Sascha Marx; Maximilian Splittstöhser; Frederik Kinnen; Eileen Moritz; Christy Joseph; Sebastian Paul; Heiko Paland; Carolin Seifert; Madlen Marx; Andreas Böhm; Edzard Schwedhelm; Kerstin Holzer; Stephan Singer; Christoph A Ritter; Sandra Bien-Möller; Henry W S Schroeder; Bernhard H Rauch
Journal:  Oncotarget       Date:  2018-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.